Clinic
Columbia Medical Center of Plano Subsidiary LP
Columbia Medical Center of Plano Subsidiary LP was paid $3.21M by Medicaid between Dec 2019 and Dec 2024, across 71 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
33Billing provider infoCOLUMBIA MEDICAL CENTER OF PLANO SUBSIDIARY LP
PLANO, TX 75075
PLANO, TX 75075
33aNPI1699726406assigned 05/15/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.21M
24GClaims63,311
24DCodes billed71
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#101 of 320
Median peer was paid$205K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 45 | $15.87 | |
| 2020 | 2,696 | $162K | |
| 2021 | 15,689 | $771K | |
| 2022 | 17,158 | $878K | |
| 2023 | 15,827 | $1.03M | |
| 2024incomplete | 11,896 | $363K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 7,937 | 7,602 | $1.24M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 35% | 5,379 | 4,830 | $1.12M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 5.2% | 212 | 91 | $165K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.0% | 1,677 | 1,463 | $162K |
| 80053 | Comprehensive metabolic panel | 2.8% | 3,034 | 2,474 | $90K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 2,797 | 2,041 | $79K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.5% | 817 | 705 | $47K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 1,072 | 935 | $40K |
| 87070 | <1% | 267 | 241 | $31K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,124 | 3,419 | $29K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,483 | 2,151 | $24K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 627 | 619 | $18K |
59 more codes
| 83880 | <1% | 1,575 | $15K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 630 | $15K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 188 | $14K |
| 85027 | <1% | 6,455 | $14K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 742 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,268 | $13K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 106 | $8K |
| 81025 | <1% | 957 | $6K | |
| 81001 | <1% | 939 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,088 | $6K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 189 | $5K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 225 | $5K |
| 84484 | <1% | 1,777 | $4K | |
| 81000 | <1% | 676 | $4K | |
| 93976 | <1% | 34 | $4K | |
| 81003 | <1% | 290 | $4K | |
| 76801 | <1% | 35 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 147 | $3K |
| 85610 | <1% | 2,041 | $3K | |
| 84702 | <1% | 168 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 487 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 311 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 64 | $1K |
| 83690 | <1% | 1,086 | $1K | |
| G0378 | Hospital observation service, per hour | <1% | 12 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 835 | $996.53 |
| 85730 | <1% | 1,360 | $951.25 | |
| 83735 | <1% | 492 | $901.33 | |
| 86900 | <1% | 681 | $848.53 | |
| 86901 | <1% | 675 | $818.37 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 124 | $739.54 |
| 82565 | <1% | 42 | $655.43 | |
| 87420 | <1% | 12 | $655.04 | |
| 84703 | <1% | 100 | $526.29 | |
| 88342 | <1% | 26 | $456.37 | |
| 77080 | <1% | 29 | $454.02 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 191 | $376.18 |
| 86850 | <1% | 61 | $352.91 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,081 | $290.39 |
| 87040 | <1% | 12 | $238.66 | |
| 72170 | <1% | 14 | $200.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $190.58 |
| 83605 | <1% | 112 | $186.24 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,559 | $160.26 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 310 | $90.16 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 430 | $81.70 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 158 | $46.48 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 74 | $22.32 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 176 | $17.56 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 62 | $10.62 |
| 80047 | <1% | 13 | $8.31 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 48 | $2.86 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 15 | $1.68 |
| A9270 | Non-covered item or service | 0% | 1,330 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 73 | $0.00 |
| J3490 | Unclassified drugs | 0% | 32 | $0.00 |
| 87205 | 0% | 13 | $0.00 | |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 230 | $0.00 |
| 87075 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTEIN, BRAD (CFO)